Brain tumour: scientists from Montpellier develop a revolutionary diagnostic test

Éric Rivals, a researcher at the LIRMM (Montpellier Laboratory of Informatics, Robotics and Microelectronics), Alexandre David, a biologist at the Institute of Functional Genomics, and Christophe Hirtz, head of the clinical proteomics platform at Montpellier University Hospital, are using artificial intelligence to measure the severity of the most common brain tumours, gliomas.